Start Draft guidelines for validating treatment processes

Draft guidelines for validating treatment processes

As a result, a decrease has occurred in 1) the number of TB outbreaks in health-care settings reported to CDC and 2) health-care–associated transmission of M.

The guidelines were issued in response to 1) a resurgence of tuberculosis (TB) disease that occurred in the United States in the mid-1980s and early 1990s, 2) the documentation of several high-profile health-care–associated (previously termed "nosocomial") outbreaks related to an increase in the prevalence of TB disease and human immunodeficiency virus (HIV) coinfection, 3) lapses in infection-control practices, 4) delays in the diagnosis and treatment of persons with infectious TB disease, and 5) the appearance and transmission of multidrug-resistant (MDR) TB strains.

Iademarco, MD, Renee Ridzon, MD Division of Tuberculosis Elimination, National Center for HIV, STD, and TB Prevention The material in this report originated in the National Center for HIV, STD, and TB Prevention, Kevin Fenton, MD, Ph D, Director; and the Division of Tuberculosis Elimination, Kenneth G. Telephone: 404-639-8310; Fax: 404-639-8604; E-mail: [email protected] In 1994, CDC published the Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Facilities, 1994.

Various setting types might be present in a single facility.

Health-care settings include inpatient settings, outpatient settings, and nontraditional facility-based settings.

CDC prepared the current guidelines in consultation with experts in TB, infection control, environmental control, respiratory protection, and occupational health.

The new guidelines have been expanded to address a broader concept; health-care–associated settings go beyond the previously defined facilities.

​​The list below includes information and guidance published in the last 12 months.